Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment

Sanna-Kaisa Herukka, Anja Hviid Simonsen, Niels Andreasen, Ines Baldeiras, Maria Bjerke, Kaj Blennow, Sebastiaan Engelborghs, Giovanni B. Frisoni, Tomasz Gabryelewicz, Samantha Galluzzi, Ron Handels, Milica G. Kramberger, Agnieszka Kulczynska, Jose Luis Molinuevo, Barbara Mroczko, Agneta Nordberg, Catarina Resende Oliveira, Markus Otto, Juha O. Rinne, Uros RotEsen Saka, Hilkka Soininen, Hanne Struyfs, Silvia Suardi, Pieter Jelle Visser, Bengt Winblad, Henrik Zetterberg, Gunhild Waldemar*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)285-295
Number of pages11
JournalAlzheimer's & Dementia
Volume13
Issue number3
DOIs
Publication statusPublished - Mar 2017

Keywords

  • Alzheimer's disease
  • Biomarkers
  • CSF
  • Diagnostics
  • GRADE
  • Mild cognitive impairment
  • Recommendations
  • POSITRON-EMISSION-TOMOGRAPHY
  • APOLIPOPROTEIN-E GENOTYPE
  • ASSOCIATION WORKGROUPS
  • PHOSPHORYLATED-TAU
  • NATIONAL INSTITUTE
  • COST-EFFECTIVENESS
  • GRADING QUALITY
  • CSF BIOMARKERS
  • DEMENTIA
  • METAANALYSIS

Cite this

Herukka, S-K., Simonsen, A. H., Andreasen, N., Baldeiras, I., Bjerke, M., Blennow, K., Engelborghs, S., Frisoni, G. B., Gabryelewicz, T., Galluzzi, S., Handels, R., Kramberger, M. G., Kulczynska, A., Luis Molinuevo, J., Mroczko, B., Nordberg, A., Oliveira, C. R., Otto, M., Rinne, J. O., ... Waldemar, G. (2017). Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment. Alzheimer's & Dementia, 13(3), 285-295. https://doi.org/10.1016/j.jalz.2016.09.009